The vast majority of these — 129 million — qualify to acquire it for weight loss based on their own BMI and weight-connected troubles like superior hypertension. Which is more and more people than are qualified to acquire statins.The drug semaglutide accounted for an estimated 88% of latest GLP-one prescriptions written in 2023 and reviewed via